(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

NITROXOLINA PARA USO NO TRATAMENTO DE NEUROFIBROMA CUTÂNEO

Em AnáliseInvention PatentPCT · GB2022051442
Talk to an expert

Application data

Invention Patent NITROXOLINA PARA USO NO TRATAMENTO DE NEUROFIBROMA CUTÂNEO de HEALX LTD — IPC A61K 31/4184
Invention Patent NITROXOLINA PARA USO NO TRATAMENTO DE NEUROFIBROMA CUTÂNEO de HEALX LTD — IPC A61K 31/4184. Drawing published by the INPI in the Industrial Property Gazette.

Number

112023025789

Type

Invention Patent

Filing

06/09/2022

Publication

02/27/2024

PCT

GB2022051442
View on INPI

Progress at the INPI

  1. Filing06/09/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 06/09/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 02/27/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

HEALX LTD

GB

Inventors

D. B. (pessoa física)

GB

Technical data

IPC Classification

A61K 31/4184A61K 31/47A61K 45/06A61P 35/00

Priority claims

GB

2108224.3 · 06/09/2021

Abstract

NITROXOLINA PARA USO NO TRATAMENTO DE NEUROFIBROMA CUTÂNEO. A presente invenção refere-se a uma composição compreendendo nitroxolina, ou um sal farmaceuticamente aceitável da mesma, para uso no tratamento ou prevenção de um neurofibroma cutâneo

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

02/27/2024

RPI 2773

Alteração de dados cadastrais

#1.1

12/19/2023

RPI 2763

Related

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.